Synopsis
Synopsis
0
JDMF
0
KDMF
0
FDA Orange Book
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acetate, Chlorhexidine
2. Chlorhexidine
3. Chlorhexidine Acetate
4. Chlorhexidine Hydrochloride
5. Hydrochloride, Chlorhexidine
6. Mk 412a
7. Mk-412a
8. Mk412a
9. Novalsan
10. Sebidin A
11. Tubulicid
1. 56-95-1
2. Chlorhexidine Acetate
3. Bactigras
4. Hibitane Diacetate
5. Chlorhexidine (diacetate)
6. Chlorhexidine Acetate [usp]
7. 5908zuf22y
8. 206986-79-0
9. Chlorohexidine Diacetate
10. Nsc-526936
11. 1,1'-hexamethylenebis(5-(p-chlorophenyl)biguanide) Diacetate
12. Chlorhexidine Acetate (usp)
13. Acetic Acid;(1e)-2-[6-[[amino-[(e)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine
14. Caswell No. 481e
15. 1,1'-hexamethylenebis[5-(4-chlorophenyl)biguanide] Diacetate
16. 10,040 Diacetate
17. Chlorhexidine Di(acetate)
18. Bis(p-chlorophenyldiguanidohexane) Diacetate
19. Chlorhexidine Acetate (van)
20. 1,6-bis(p-chlorophenylbiguanido)hexane Diacetate
21. 1,6-bis(5-(p-chlorophenyl)biguandino)hexane Diacetate
22. Einecs 200-302-4
23. 1,1'-hexamethylenebis(5-(p-chlorophenyl)biguanide)diacetate
24. 1,1'-hexamethylene Bis(5-(p-chlorophenyl)biguanide) Diacetate
25. Epa Pesticide Chemical Code 045502
26. Nsc 526936
27. 1,1'-hexamethylenebis[5-(p-chlorophenyl)biguanide] Diacetate
28. Unii-5908zuf22y
29. 1,6-bis(n5-[p-chlorophenyl]-n1-biguanido)hexane
30. 1,1'-hexamethylenebis(5-(4-chlorophenyl)biguanide) Diacetate
31. N',n'''''-hexane-1,6-diylbis[n-(4-chlorophenyl)(imidodicarbonimidic Diamide)] Diacetate
32. Nolvasan (tn)
33. Acetic Acid;1-(4-chlorophenyl)-3-[n-[6-[[n-[n-(4-chlorophenyl)carbamimidoyl]carbamimidoyl]amino]hexyl]carbamimidoyl]guanidine
34. 1,6-di(4'-chlorophenyldiguanidino)hexane Diacetate
35. Chlorhexidini Diacetas
36. Chlorhexidine Diacetate Salt
37. Chlorhexidine Acetate Hydrate
38. 2,4,11,13-tetraazatetradecanediimidamide, N,n''-bis(4-chlorophenyl)-3,12-diimino-, Diacetate
39. Dsstox_cid_12345
40. Dsstox_rid_78918
41. Dsstox_gsid_32345
42. Schembl12043
43. Chembl486819
44. Dtxsid7032345
45. Chebi:81711
46. 1,1'-hexamethylenebis(5-(p-chlorophenyl)biguanide), Diacetate
47. Chlorhexidine Diacetate [mi]
48. Tox21_302363
49. Mfcd00150042
50. S6288
51. Chlorhexidine Acetate [mart.]
52. Chlorhexidine Diacetate [inci]
53. Akos007930358
54. Biguanide, 1,1'-hexamethylenebis(5-(p-chlorophenyl)-, Diacetate
55. Chlorhexidine Acetate [usp-rs]
56. Cs-w014415
57. Hy-w013699
58. 2,4,11,13-tetraazatetradecanediimidamide, N,n'-bis(4-chlorophenyl)-3,12-diimino-, Diacetate
59. Cas-56-95-1
60. Chlorhexidine Diacetate [who-dd]
61. Chlorhexidine Diacetate [who-ip]
62. Ncgc00091025-03
63. Ncgc00255277-01
64. As-12655
65. Chlorhexidine Acetate [green Book]
66. Chlorhexidine Acetate [usp Monograph]
67. Chlorhexidini Diacetas [who-ip Latin]
68. Chlorhexidine Diacetate [ep Monograph]
69. C18372
70. D07669
71. 012c532
72. 986c790
73. A831251
74. W-109258
75. Chlorhexidine Diacetate 100 Microg/ml In Acetonitrile:water
76. Chlorhexidine Diacetate Salt Hydrate, Bis(biguanide) Antimicrobial
77. Chlorhexidine Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
78. (1e)-2-[6-[[azanyl-[(e)-[azanyl-[(4-chlorophenyl)amino]methylidene]amino]methylidene]amino]hexyl]-1-[azanyl-[(4-chlorophenyl)amino]methylidene]guanidine; Ethanoic Acid
79. Acetic Acid; 2-[amino-[6-[[amino-[(e)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexylimino]methyl]-1-(4-chlorophenyl)guanidine
80. N,n'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca-nediimidamide, Diacetate
Molecular Weight | 625.5 g/mol |
---|---|
Molecular Formula | C26H38Cl2N10O4 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 13 |
Exact Mass | 624.2454551 g/mol |
Monoisotopic Mass | 624.2454551 g/mol |
Topological Polar Surface Area | 252 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 680 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anti-Infective Agents, Local
Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)
Disinfectants
Substances used on inanimate objects that destroy harmful microorganisms or inhibit their activity. Disinfectants are classed as complete, destroying SPORES as well as vegetative forms of microorganisms, or incomplete, destroying only vegetative forms of the organisms. They are distinguished from ANTISEPTICS, which are local anti-infective agents used on humans and other animals. (From Hawley's Condensed Chemical Dictionary, 11th ed) (See all compounds classified as Disinfectants.)
Mouthwashes
Solutions for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. (From Boucher's Clinical Dental Terminology, 4th ed) (See all compounds classified as Mouthwashes.)
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33952
Submission : 2019-06-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9573
Submission : 1992-03-10
Status : Active
Type : II
Certificate Number : CEP 2018-123 - Rev 02
Issue Date : 2024-02-19
Type : Chemical
Substance Number : 657
Status : Valid
NDC Package Code : 53296-0009
Start Marketing Date : 2010-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16253
Submission : 2002-11-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18840
Submission : 2005-10-03
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4387
Submission : 1981-11-23
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13124
Submission : 1998-07-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23018
Submission : 2009-05-20
Status : Inactive
Type : II
Date of Issue : 2022-04-04
Valid Till : 2024-10-07
Written Confirmation Number : WC-0509A1
Address of the Firm :
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Reply
15 Nov 2018
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
83
PharmaCompass offers a list of Chlorhexidine Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorhexidine Acetate manufacturer or Chlorhexidine Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorhexidine Acetate manufacturer or Chlorhexidine Acetate supplier.
PharmaCompass also assists you with knowing the Chlorhexidine Acetate API Price utilized in the formulation of products. Chlorhexidine Acetate API Price is not always fixed or binding as the Chlorhexidine Acetate Price is obtained through a variety of data sources. The Chlorhexidine Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sebidin A manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sebidin A, including repackagers and relabelers. The FDA regulates Sebidin A manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sebidin A API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sebidin A manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sebidin A supplier is an individual or a company that provides Sebidin A active pharmaceutical ingredient (API) or Sebidin A finished formulations upon request. The Sebidin A suppliers may include Sebidin A API manufacturers, exporters, distributors and traders.
click here to find a list of Sebidin A suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sebidin A DMF (Drug Master File) is a document detailing the whole manufacturing process of Sebidin A active pharmaceutical ingredient (API) in detail. Different forms of Sebidin A DMFs exist exist since differing nations have different regulations, such as Sebidin A USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sebidin A DMF submitted to regulatory agencies in the US is known as a USDMF. Sebidin A USDMF includes data on Sebidin A's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sebidin A USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sebidin A suppliers with USDMF on PharmaCompass.
A Sebidin A CEP of the European Pharmacopoeia monograph is often referred to as a Sebidin A Certificate of Suitability (COS). The purpose of a Sebidin A CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sebidin A EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sebidin A to their clients by showing that a Sebidin A CEP has been issued for it. The manufacturer submits a Sebidin A CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sebidin A CEP holder for the record. Additionally, the data presented in the Sebidin A CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sebidin A DMF.
A Sebidin A CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sebidin A CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sebidin A suppliers with CEP (COS) on PharmaCompass.
A Sebidin A written confirmation (Sebidin A WC) is an official document issued by a regulatory agency to a Sebidin A manufacturer, verifying that the manufacturing facility of a Sebidin A active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sebidin A APIs or Sebidin A finished pharmaceutical products to another nation, regulatory agencies frequently require a Sebidin A WC (written confirmation) as part of the regulatory process.
click here to find a list of Sebidin A suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sebidin A as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sebidin A API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sebidin A as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sebidin A and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sebidin A NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sebidin A suppliers with NDC on PharmaCompass.
Sebidin A Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sebidin A GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sebidin A GMP manufacturer or Sebidin A GMP API supplier for your needs.
A Sebidin A CoA (Certificate of Analysis) is a formal document that attests to Sebidin A's compliance with Sebidin A specifications and serves as a tool for batch-level quality control.
Sebidin A CoA mostly includes findings from lab analyses of a specific batch. For each Sebidin A CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sebidin A may be tested according to a variety of international standards, such as European Pharmacopoeia (Sebidin A EP), Sebidin A JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sebidin A USP).